STAG2 and transitional cell carcinoma: Despite the detailed mechanism of STAG2 leading to the pathogenesis of transitional cell carcinoma is still not known, the high-frequency recurrent mutant gene is indeed a new pathway associated with transitional cell carcinoma in the SCCS process of transitional cell bladder cancer (45).